Psoriasis: Clinical Trials

11 trials for Psoriasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 unknown. 11 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 111Unknown 11
Phase 23Unknown 3

Follow Psoriasis: new trials by email Literature Review of Psoriasis trials Research Report on Psoriasis

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study of ICP-488 in Healthy Subjects and Patients With Psoriasis
ICP-488, Placebo - Psoriasis
Phase 1UnknownBeijing InnoCare Pharma Tech Co., Ltd.1542022-07-292023-04-18
Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis
CT303 - Moderate to Severe Plaque Psoriasis
Phase 1UnknownGC Cell Corporation242021-10-252022-03-18
Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis
Umbilical cord mesenchymal stem cells - Mesenchymal Stromal Cells, Psoriasis
Phase 1 / Phase 2UnknownGuangdong Provincial Hospital of Traditional Chinese Medicine52021-08-312021-02-09
An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis Patients
Secukinumab 300 MG, Secukinumab 150 MG, Methotrexate - Psoriatic Arthritis
Phase 1UnknownPeking Union Medical College Hospital602021-07-152021-07-20
Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis
PSORI-CM01 formula, Gu Ben Hua Yu formula, adipose-derived multipotent mesenchymal stem cells - Traditional Chinese Medicine, Drug Effect
Phase 1 / Phase 2UnknownGuangdong Provincial Hospital of Traditional Chinese Medicine162021-03-172023-08-24
A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers
Hemay005 - Psoriasis
Phase 1UnknownTianjin Hemay Bio-Tech Co., Ltd122018-10-102018-07-05
Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects
Hemay005, Placebo - Psoriasis
Phase 1UnknownTianjin Hemay Bio-Tech Co., Ltd242018-07-102018-10-02
Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis
Low-dose UC-MSCs, High-dose UC-MSCs, Methotrexate - Moderate and Severe Plaque Psoriasis
Phase 1UnknownTianjin Ever Union Biotechnology Co., Ltd.572018-06-012018-04-20
Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis
FURESTEM-CD Inj. - Psoriasis
Phase 1UnknownKang Stem Biotech Co., Ltd.92018-01-172018-03-14
BE Study in Patients - Methotrexate Tablets
Methotrexate - Amneal, Methotrexate - DAVA - Psoriasis, Rheumatoid Arthritis
Phase 1UnknownAmneal Pharmaceuticals, LLC482016-08-012016-10-21
A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118
IDP-118 Low Strength, IDP-118 High Strength - Plaque Psoriasis
Phase 1 / Phase 2UnknownDow Pharmaceutical Sciences602012-06-012013-04-25

Narrower conditions

Arthritis, Psoriatic (1)  ·  Arthritis, Rheumatoid (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Lymphoma, Follicular (1)

Broader conditions

Skin Diseases (11)  ·  Skin Diseases, Papulosquamous (11)  ·  Skin and Connective Tissue Diseases (11)  ·  Arthritis (2)  ·  Immune System Diseases (2)  ·  Joint Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Autoimmune Diseases (1)  ·  Bone Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Connective Tissue Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)

Interventions

Methotrexate (3)  ·  Hemay005 (2)  ·  secukinumab (1)

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine (2)  ·  Tianjin Hemay Bio-Tech Co., Ltd (2)  ·  Amneal Pharmaceuticals, LLC (1)  ·  Beijing InnoCare Pharma Tech Co., Ltd. (1)  ·  Dow Pharmaceutical Sciences (1)  ·  GC Cell Corporation (1)  ·  Kang Stem Biotech Co., Ltd. (1)  ·  Peking Union Medical College Hospital (1)  ·  Tianjin Ever Union Biotechnology Co., Ltd. (1)

Countries

China (6)  ·  South Korea (2)  ·  India (1)  ·  United States (1)

Top investigators

Hongyun Wang, Doctor (2)  ·  Chuanjian Lu, PhD (1)  ·  Chunlei Zhang, doctor (1)  ·  Chunting Li, doctor (1)  ·  Jinzhu Guo, doctor (1)  ·  Prayag N Shah, MD (1)  ·  Qianjin Lu (1)  ·  Seongjin Jo (1)  ·  Taeyoon Kim (1)  ·  Todd Plott, MD (1)  ·  Wenhui Wang, doctor (1)  ·  Xin Guan, doctor (1)

Results publications

PMID 41545329